is being presented by Kevin McCabe & Dr. Eldora Ellison, Directors, Biotechnology/Chemical and Litigation Groups Sterne, Kessler, Goldstein & Fox P.L.L.C. and airs on Tuesday, June 7th, 2011. For more details, or to register please visit our site at www.fxconferences.com
Sooner or later, nearly all high technology companies encounter one or more patents that may present a roadblock to bringing a product to market or to conducting important research.
This audio conference presentation provides an overview of the legal tools available in the United States to help address such “problem” patents. In particular, our speakers provide a detailed discussion of patent re-examinations and the interplay between re-examinations and litigation. Additionally, the presentation looks at other mechanisms that may be used when one encounters a problematic patent, such as licensing, design-arounds, protests, interferences, and arbitration.
This presentation is informative both for companies that are concerned with patents held by others, as well as companies that may seek to enforce their own patents and thus subject such patents to validity challenges. The knowledge of these tools, and their various pros and cons, provided through this presentation give companies needed information to assist their strategic decision-making.
Showing posts with label Dr. Eldora Ellison. Show all posts
Showing posts with label Dr. Eldora Ellison. Show all posts
Tuesday, May 24, 2011
Wednesday, April 6, 2011
Best Practices for Building IP and Conducting Due Diligence Investigations
is being presented by Kevin McCabe & Dr. Eldora Ellison, Directors, Biotechnology/Chemical and Litigation Groups, with Sterne, Kessler, Goldstein & Fox P.L.L.C. and airs on Wednesday, May 4th, 2011. For more details or to register, please visit our site at www.fxconferences.com
There has already been a flurry of M&A activity in the life sciences and health technologies fields 2011. This audio conference provides attendees with best practices guidance on how to prepare their intellectual property (IP) for a successful partnering transaction.
Drawing upon a series of case studies involving recent transactions, the presenters discuss what worked well and why, and also the mistakes that could have been avoided. This conference should be of keen interest to companies currently involved in or contemplating entering into a partnering deal, as well the investment community.
There has already been a flurry of M&A activity in the life sciences and health technologies fields 2011. This audio conference provides attendees with best practices guidance on how to prepare their intellectual property (IP) for a successful partnering transaction.
Drawing upon a series of case studies involving recent transactions, the presenters discuss what worked well and why, and also the mistakes that could have been avoided. This conference should be of keen interest to companies currently involved in or contemplating entering into a partnering deal, as well the investment community.
Subscribe to:
Posts (Atom)